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Abstract
In the mouse, embryo culture results in a characteristic phenotype of retarded embryo
preimplantation development and reduced numbers of cells within embryos. The expression of
TRP53 is central to the regulation of the cell's capacity to proliferate and survive. In this study we
found that Trp53 mRNA is expressed throughout the preimplantation stage of development. Levels
of TRP53 protein expression were low during the cleavage stages and increased at the morula and
blastocyst stages in B6 embryos collected from the reproductive tract. Embryos collected at the
zygote stage and cultured for 96 h also showed low levels of TRP53 expression at precompaction
stages. There were higher levels of TRP53 in cultured morula and the level in cultured blastocysts
was clearly increased above blastocysts collected directly from the uterus. Immunolocalization of
TRP53 showed that its increased expression in cultured blastocysts corresponded with a marked
accumulation of TRP53 within the nuclei of embryonic cells. This pattern of expression was
enhanced in embryos produced by in vitro fertilization and subjected to culture. The TRP53 was
transcriptionally active since culture also induced increased expression of Bax, yet this did not
occur in embryos lacking Trp53 (Trp53-/-). The rate of development of Trp53-/- zygotes to the
blastocyst stage was not different to wildtype controls when embryos were cultured in groups of
ten but was significantly faster when cultured individually. The results show that zygote culture
resulted in the accumulation of transcription activity of TRP53 in the resulting blastocysts. This
accounts for the adverse effects of culture of embryos individually, but does not appear to be the
sole cause of the retarded preimplantation stage growth phenotype associated with culture in vitro.
Introduction
Assisted reproductive technologies (ART; which includes
techniques such as in vitro fertilization (IVF), intracyto-
plasmic sperm injection (ICSI), embryo cryopreservation
and embryo donation) are now central to the treatment of
infertility in humans. These techniques are successful
treatments, yet an individual embryo produced by these
methods has less than a 50% chance of forming a viable
neonate. Much of the loss of embryo viability occurs in
the pre- and peri-implantation phases.
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The use of animal models, particularly the mouse, has
been important for the development of embryo culture
procedures. In the mouse it is well known that embryo
manipulation and culture results in a characteristic phe-
notype of slow embryo development in vitro. After several
days in culture embryos have typically fewer cells and
more cells within embryos undergoing death, than corre-
sponding stage embryos collected from the reproductive
tract [1-3]. This phenotype of impaired development is
particularly severe in a range of inbred lines, such as B6
[4]. Such lines provide an attractive model for identifying
the possible causative mechanisms.
A number of cellular stressors induced by the culture envi-
ronment have been identified, and include growth and
survival factor deprivation [3,5], metabolic and substrate
imbalances [6,7], and oxidative stress [8]. In somatic cells
all these stresses are capable of activating the TRP53 stress
response pathway. Increased TRP53 expression is a
response to a wide range of genotoxic and non-genotoxic
stresses [9-11]. TRP53 is a transcription factor that has
many functions [10] including a reduction in the rate of
cycle-cell progression (for example, by the induction of
cyclin-dependent kinase inhibitors such as p21Waf1/Cip1)
or induction of cell death (by the synthesis of pro-death
mediators, such as Bax).
Mouse [12] and human embryos [13] express Trp53
mRNA. In human embryos produced by IVF its expression
was higher in embryos with poor morphology following
culture, as assessed by the degree of cytoplasmic fragmen-
tation [14]. There is much anecdotal evidence that trans-
genic over-expression of Trp53 is incompatible with early
mouse embryo development. Furthermore, increased
TRP53 activity (due to the deletion of Mdm2 [15-17]) also
results in early mouse embryonic lethality. Diabetes-
induced early embryopathy was partially ameliorated by
Trp53 deletion in a mouse model [18].
This study examined the hypothesis that IVF and culture
of embryos caused increased TRP53 expression of tran-
scriptionally active TRP53 in the mouse preimplantation
embryo.
Materials and methods
Animals
The use of animals was in accordance with the Australian
Code of Practice for the Care and Use of Animals for Sci-
entific Purpose and was approved by the Institutional Ani-
mal Care and Ethics Committee. C57BL6J (B6), Trp53-/-
and  Trp53+/+  (B6.129S2-Trp53tm1Tyj  strain extensively
backcrossed with B6) were used in experiments. All ani-
mals were housed and bred in the Gore Hill Research Lab-
oratory, St Leonards, NSW, Australia. All animals were
under 12 h light: 12 h dark cycle and had access to food
and water ad libitum. Four to eight week old females were
superovulated by intraperitoneal injection of 10 IU
equine chorionic gonadotrophin (Folligon, Intervet Inter-
national, Boxmeer, The Netherlands) followed 48 h later
by 10 IU human chorionic gonadotrophin (hCG, Choru-
lon, Intervet). Females were paired with males of proven
fertility. Pregnancy was confirmed by the presence of a
copulation plug the following morning (day 1).
Mouse embryo collection and culture
In most experiments cumulus masses or embryos were
flushed from the reproductive tract with HEPES-buffered
modified human tubal fluid medium and cultured in
modified human tubal fluid medium (mod-HTF) [5]. All
components of the media were tissue culture grade
(Sigma Chemical Company, St Louis, MO) and contained
3 mg bovine serum albumin/mL unless otherwise stated
(CSL Ltd., Melbourne, Vic., Australia). Fertilization in vitro
(IVF) was performed as previously described [19]. Briefly,
epididymides from males of proven fertility were punc-
tured and the sperm squeezed into medium and allowed
to disperse in mod-HTF media for 40 minutes. Motile
sperm (0.5 × 106) was added to groups of oocytes within
their cumulus masses. Fertilization rate was assessed at 5–
6 h and all fertilized oocytes transferred to mod-HTF
media. Fresh zygotes were collected 20–21 h after hCG
and freed from their cumulus cells by brief exposure to
300 IU hyaluronidase (Sigma) in HEPES-buffered mod-
HTF. Embryos were recovered in minimal volume and
assigned to various treatments as required in mod-HTF.
Embryos were cultured in 10 μL volumes in 60-well HLA
plates (LUX 5260, Nunc, Naperville, IL) overlaid by
approximately 2 mm of heavy paraffin oil (Sigma).
Embryos were cultured individually or in groups of 10.
Culture was at 37°C in 5% CO2 for the periods indicated
in individual experiments. The developmental stage and
morphology of embryos was assessed by visualizing the
embryos with an inverted phase contrasted microscope
(Nikon Diaphot, Japan) at 24 h interval after zygote col-
lection. Fresh blastocysts were collected by flushing each
uterine horn with 1 mL of HEPES buffered mod-HTF.
Cell lines
Two cell lines were used as positive control material. F9
(mouse choriocarcinoma) and T47D (estrogen receptor-
positive breast cancer cell) cell lines were routinely grown
in DMEM supplemented with 10% fetal calf serum, 0.1
IU/mL insulin, 2 mM glutamine, 100 IU/mL penicillin,
and 100 μg/mL streptomycin in a humidified atmosphere
containing 5% CO2 and 95% air at 37 C. The cells were
grown to confluence and cells collected for analysis,
washed three times in PBS, counted and then used a indi-
cated.Reproductive Biology and Endocrinology 2006, 4:61 http://www.rbej.com/content/4/1/61
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Reverse transcriptase polymerase transcription factor 
(RTPCR)
RTPCR was performed as previously described [20],
briefly embryos were collected fresh from the reproduc-
tive tract. The embryos were washed 3 times in cold PBS
(Ca2+- Mg2+-free Dubbecco's phosphate buffer saline
(Sigma)) and then transferred in a minimal volume to 30
μl of PCR Gold buffer (50 mM KCl, 15 mM Tris-HCl, pH
8.0) in diethyl pyrocarbonate (DEPC, Sigma) treated Mil-
liQ water containing 1 IU RNAse inhibitor (Applied Bio-
systems, Lincoln Centre Drive, Foster City, CA). The
embryos were lyzed by 3 cycles of freezing in liquid nitro-
gen and thawing (with vortexing) and subject to RTPCR.
Reverse transcription was in 12.5 U of murine leukemia
virus reverse transcriptase (MuLV), 1 U RNase inhibitor, 4
mM MgCl2, 50 mM KCl, 15 mM Tris-HCl pH 8.0, 0.5 mM
dNTPs (Applied Biosystems), 1.5 μM allele specific reverse
primer. The reactions were incubated for 10 min in room
temperature, 30 min at 42°C and 2 min at 99°C. Two
negative controls were included: no reverse transcription
enzyme; and no template to test for extraneous DNA or
RNA contaminations, respectively. PCR reaction specific
products included 3 μl cDNA template (equivalent to 0.3
embryo), 1.5 μL Amplitaq Gold DNA polymerase, 4 mM
MgCl2, 50 mM KCl, 15 mM Tris-HCl pH 8.0, 0.5 mM
dNTP (Applied Biosystems) and 5% (v/v) DMSO
(Sigma), 1.5 μM each of gene specific primers. The reac-
tions were incubated for 10 min at 94°C and 40 cycles of
15 seconds at 94°C and 1 min at 58°C in a Corbett Ther-
mal Reactor. PCR reaction products were analyzed by elec-
trophoresis on 2% (w/v) agarose gel stained with
ethidium bromide to visualize PCR products on UV trans-
luminator. Fragments were verified by size and represent-
ative samples were had sequence analyzed (SUPAMAC,
Redfern, NSW, Australia).
Primers were obtained from Sigma-Genosys (Sigma). β-
Actin was used as a positive control The sequence of oli-
gonucleotide primers and the product size were as fol-
lows:  β-Actin  (Accession number MMACTBR) 5'-
CGTGGGCCGCCCTAGGCACCA, 3'-TTGGCCTTAGGGT-
TCAGGGGG, 243 bp. Trp53 5' – GGAGTCTTCCAGTGT-
GATGAT 3'-GGGACAGCCAAGTCTGTTATG 429 bp.
Western blotting analysis
Western blotting analysis was performed as previously
described [21]. Embryos or oocytes were collected and
washed 3 times in cold PBS and transferred in a maximum
volume of 1.5 μL PBS into 1.5 μL of 2X extraction buffer
supplemented with protease and phosphatase inhibitors
(2X PBS, 2% (v/v) Triton X-100, 24 mM deoxycholic acid,
0.2% (w/v) sodium dodecyl sulfate, 20 mM NaF, 20 mM
Na4P2O7, 2 mM PMSF, 3.08 μM aprotinin, 42 μM leupep-
tin and 2.91 μM pepstatin A – all from Sigma). The
embryos were lyzed by three cycles of freezing in liquid
nitrogen and thawing (with vortexing). Protein samples
were diluted with 1 μL of 5X Laemmli buffer (50 mM Tris-
HCl, 5 mM EDTA pH 8.0, 12.5% (w/v) sodium dodecyl
sulfate, 0.05% (w/v) bromophenol blue and 25% beta-
mercaptoethanol), incubated 10 min at 60°C and size
separated using 20% homogenous SDS polyacrylamide
gels (Pharmacia Sweden) on a PhastSystem apparatus (GE
Healthcare, Castle Hill, NSW, Australia). Proteins were
blotted into PVDF membranes (Hybond-P, GE Health-
care) in a semi-dry blotting apparatus overnight using
transfer buffer (12 mM Tris PH 7.0, 96 mM Glycine and
20% (v/v) methanol). Nonspecific binding was blocked
by 5% (w/v) skim milk in PBS supplemented with 0.05%
(v/v) tween-20 (PBST) at room temperature for 1 h. Mem-
branes were probed with primary antibody overnight at
4°C in 5% skim milk in PBST. A horseradish peroxidase
conjugated second antibody was applied for 1 h at room
temperature. Membranes were developed with either Pico
SuperSignal Chemiluminescent Substrates (Pierce, Rock-
ford, IL, USA) for 5 min at room temperature and exposed
to X Ray film (CL-XPosure Film – Pierce).
Reprobing membranes with Lis-1 antibody allowed
assessment of changes in levels of a constitutively
expressed protein. Membranes were incubated in freshly
made denaturing solution [7 M Guanidine Hydrochloride
(Sigma), 50 mM Tris pH 8.0 (BDH), 2 mM EDTA (Sigma),
0.25% skim milk (Bonlac Foods Limited, Melbourne, Vic.
Australia), 2 mM dithiothreitol (Promega Corporation,
Madison, Wis., USA), 0.3% (w/v) BSA (CSL)] for 1 min at
room temperature with mixing. Membranes were than
rinsed twice with renaturation buffer [50 mM Tris pH 7.5
(BDH Laboratory Supplies, Poole, Dorset, England), 100
mM NaCl (Sigma), 2 mM EDTA (Sigma), 0.1% (v/v)
tween-20 (Cat #P-7949 Sigma), 0.3% BSA (CSL)] and
incubated with mixing in renaturation buffer for 30 min
at room temperature. The membranes were than washed
in PBST for 2 min to remove any remaining renaturation
buffer, blocked and than re-probed with Lis-1 antibody.
Primary antibodies were 1:200 anti-TRP53 (Ab-7) poly-
clonal antibody (Cat No: PC35, Oncogene Research Prod-
ucts, Merck, Kilsyth, Victoria, Australia) or 1:200 anti-Bax
(P-19) polyclonal (Cat No: sc-526, Santa Cruz Biotech-
nology, Santa Cruz, CA.). TRP53 analysis was performed
on groups of 30 embryos, for Bax the analysis was per-
formed on the numbers shown in results.
Gels were digitally photographed and analyzed using Lab-
Works Image Acquistion and Analysis Software (Version
4.5.00.0; Ultra-Violet Products Ltd, Camdride, UK), using
the area density tool. Bands were marked with the area of
interest tool and optical density measured. Normalised
optical density (OD, arbitrary units) of the p53 band, rel-
ative to its corresponding Lis-1 band was defined as the
OD p53/OD Lis-1*100.Reproductive Biology and Endocrinology 2006, 4:61 http://www.rbej.com/content/4/1/61
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Immunofluorescence
Embryos were washed 3 times in PBS with 0.1% BSA,
0.1% tween-20 and 0.2% (w/v) sodium azide (washing
buffer), fixed with 2% paraformaldehyde (w/v) (Sigma)
for 30 min and then permeabilized with 2% paraformal-
dehyde with 0.3% Tween-20 (Sigma) at room tempera-
ture for 30 min. Embryos were washed 3 times in washing
buffer, blocked in 2% BSA and 30% serum for 3 h, and
stained overnight at 4°C with primary antibodies: 1:300
anti-TRP53 (Ab-7) polyclonal antibody; or 1:100 anti-Bax
(P-19) polyclonal (Cat No: sc-526, Santa Cruz Biotech-
nology). For each primary antibody an equivalent concen-
tration of isotype control immunoglobulin was used as a
negative control. Primary antibodies were detected by sec-
ondary antibodies coupled to FITC for 1 h at room tem-
perature. Optical sectioning was performed with a Bio-
Rad Radiance Confocal microscope, using a Nikon Plan
Apo 60 X/1.4 oil emersion objective. Images were cap-
tured using Lasersharp 2000, Version 4.0 (BioRad). Micro-
scope and laser settings were adjusted such that no
fluorescence was observed with non-immune controls. A
given antibody were observed with these same settings.
All images were equatorial 1.5 μm optical sections gener-
ated by confocal microscopy. Greyscale images were con-
verted to pseudocolor representation of staining intensity.
Whole section imaging was performed with mercury lamp
UV illumination and epifluorescence on a Nikon
Optiphot microscope with an Olympus DPlan Apo 40 UV
objective. Images were subjected to deconvolution using
Image-Pro plus (Sharpstack, Media Cybernetics, Inc. Sil-
ver Spring, MD) and staining intensity represented by
pseudocolor.
Statistical analysis
Statistical analyses were performed with SPSS statistical
package (Version 11.5, SPSS, Chicago, IL). The proportion
of embryos developing to a given developmental land-
mark following culture was assessed by binary logistic
regression analysis, treating the proportion developing to
a given landmark as the dichotomous dependent variable
and the treatments and experimental replicates as covari-
ates in the model. The effects of treatments on the number
of cells were assessed using univariate regression analysis
within the General Linear Model.
Results
Cultured B6 zygotes developed at a significantly slower
rate to the blastocyst stage than did equivalent embryos
that developed in the reproductive tract (p < 0.001) (Fig.
1A). Most embryos were morphological blastocysts 89 h
after hCG when development occurred in the reproduc-
tive tract but less then 20% when development was in
vitro. This slower rate of morphological development was
accompanied by a slower rate of cell proliferation.
Embryos developing in the reproductive tract up to 89 h
after hCG administration possessed around twice as many
cells as those cultured (p < 0.001) (Fig. 1B). By 113 h after
hCG those embryos developing in the reproductive tract
had commenced implantation (and were not capable of
being retrieved from the uterus by flushing), while those
cultured in vitro were still retarded compared with the
fresh 89 h blastocysts (p < 0.01) and still had fewer cells (p
< 0.01) than 89 h blastocyst from the uterus (Fig. 1A).
Embryos expressed Trp53 mRNA at all preimplantation
developmental stages examined (Fig. 2). TRP53 is gener-
ally considered to be constitutively expressed in most cell
types, and its cellular concentration is largely regulated by
its rate of degradation. Thus, an understanding of any
potential role for TRP53 in embryo development is best
analyzed at the level of protein expression. TRP53 expres-
sion was detected by Western blotting analysis in all pre-
implantation stages (Fig. 3). Densitometric analysis (Fig.
3) showed that for embryos collected directly from the
reproductive tract, expression was at low levels at the pre-
compaction stages. In morula stage embryos there was
evidence of an increase in expression and expression was
higher again in blastocyst stage embryos. For embryos cul-
tured from the zygote stage there were similar levels of
TRP53 expression during the pre-compaction stages as
observed in embryos collected direct from the reproduc-
tive tract. At the morula stage expression was greater and
in the blastocyst there was a marked increase in expression
in cultured embryos compared with blastocysts collected
fresh from the reproductive tract (Fig. 3).
Immunolocalization showed that the increased TRP53
expression in cultured embryos was accompanied by a
marked accumulation of TRP53 within the nuclei of some
embryonic cells (Fig. 4). It was also shown that produc-
tion of embryos by IVF followed by culture caused higher
levels of TRP53 expression compared with culture of
zygotes fertilized in the reproductive tract.
TRP53 is a transcription factor. It acts to promote tran-
scription of many important proteins, including Bax. The
increased TRP53 expression in cultured embryos was
apparently transcriptionally active since Western blotting
analysis showed that Bax was expressed at high levels in
IVF and cultured embryos compared with blastocysts col-
lected direct from the uterus (Fig. 5A). Whole embryo
immunolocalization shows that the elevated expression
of Bax occurred throughout the cultured blastocysts (Fig.
5B). Bax expression was not observed in cultured Trp53-/-
embryos  (Fig. 5B). This result demonstrates that the
enhanced expression of TRP53 in cultured embryos was
transcriptionally active.
Embryos are more susceptible to loss of viability in culture
if they are cultured individually, compared with those cul-Reproductive Biology and Endocrinology 2006, 4:61 http://www.rbej.com/content/4/1/61
Page 5 of 10
(page number not for citation purposes)
The rate of development of cultured zygotes compared with embryos collected from the reproductive tract at the same time  after the administration of ovulatory hCG (h) Figure 1
The rate of development of cultured zygotes compared with embryos collected from the reproductive tract at 
the same time after the administration of ovulatory hCG (h). No embryos could be flushed from the uterus at 113 h 
since implantation had commenced (not applicable). Numbers shown in brackets are the number of embryos examined. (A) 
The proportion of embryos that were morphological blastocysts. (B) The total number of cells present in the blastocysts 
shown in Fig.1A (mean + SEM).Reproductive Biology and Endocrinology 2006, 4:61 http://www.rbej.com/content/4/1/61
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tured in groups. Figure 6 shows that Trp53+/+ zygotes cul-
tured individually had significantly poorer development
to the blastocyst stage than did embryos cultured in
groups of ten (p < 0.001). This adverse effect of individual
culture was significantly (p < 0.01) alleviated in Trp53-/-
embryos. The results show that absence of Trp53 did not
Expression of TRP53 in embryos at various developmental stages Figure 3
Expression of TRP53 in embryos at various developmental stages. Densitometric analysis of TRP53 expression as 
shown in inset. Optical density of p53 band/Lis-1 band *100. The numbers on X-axis represent – Cultured: embryos were col-
lected at the zygote stage and cultured for: (1) 24 h, (2) 48 h, (3) 72 h, (4) 90 h. Fresh: were collected directly from the repro-
ductive tract at the (1) zygote, (2) 2-cell, (3) morula, and (4) blastocyst stages. (5) A positive control for the expression of 
TRP53 was the analysis of ~1000 T47D breast cancer cells. Inset – Western blotting analysis of 30 embryos at various devel-
opment stages. After analysis of TRP53 expression membranes were stripped and re-probed for expression of the constitu-
tively expressed Lis-1 protein. The results are representative of 3 replicates. The numbers correspond to those on the graph.
Expression of Trp53 mRNA within preimplantation stage embryos Figure 2
Expression of Trp53 mRNA within preimplantation stage embryos. RTPCR was performed with specific primers to 
detect β-Actin (positive control) or Trp53. The negative control (No RT) – Trp53 primers but no reverse transcriptase. 1. liver 
mRNA positive control, 2. oocytes. 3. zygotes. 4. early 2-cell stage. 5. late 2-cell stage, 6. morulae, and 7. blastocyst. Each anal-
ysis was performed on groups of 20 embryos and results are representative of 4 replicates.Reproductive Biology and Endocrinology 2006, 4:61 http://www.rbej.com/content/4/1/61
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prevent the retarded development of embryos in vitro in
groups, but did prevent the further retardation induced by
culture at low embryo densities.
Discussion
This study shows that culture of B6 zygotes resulted in
their retarded development compared with equivalent age
embryos developing in the reproductive tract. Embryos
produced Trp53 mRNA throughout the preimplantation
stage, confirming findings in other strains [12]. TRP53
protein was also expressed at relatively low levels during
the normal preimplantation phase development. This low
level of expression is consistent with the finding that
TRP53 is not required for normal development of the
embryo in vivo, since Trp53-/- embryos are viable [22]. In
blastocysts collected directly from the reproductive tract
there is little obvious accumulation of TRP53 within
nuclei and little expression of Bax, a TRP53 transcription
product. These observations suggest a latency of expres-
sion and action of TRP53 in the embryo within the repro-
ductive tract. Such latency is to be expected within normal
cells [23]. By contrast, the culture of embryos from the
zygote stage or their production by IVF (and subsequent
culture) resulted in a marked increase in the expression of
TRP53 in the post compaction embryos. This increased
expression was accompanied by pronounced nuclear
accumulation of TRP53. Culture also resulted in increased
expression of Bax, and this was TRP53-dependent. Thus,
TRP53 expression and nuclear localization in culture
embryos was transcriptionally active. This result does not
of itself show that Bax is a major effector of TRP53 expres-
sion in the cultured early embryo. However, the resistance
of Bax-/- mouse blastocysts (and partial resistance of Bax+/
- blastocysts) to apoptosis induced by the presence of high
Effect of IVF and culture on TRP53 localization in blastocysts Figure 4
Effect of IVF and culture on TRP53 localization in blastocysts. Localization of TRP53 by indirect immunofluorescence 
in blastocysts collected from the uterus (Fresh); cultured from the zygote stage (zygotes); or cultured from the zygote stage 
after production by IVF (IVF). The plate shows images of 2 different representative embryos for each treatment. The experi-
ment was repeated 3 times with a minimum of 8 embryos for each treatment in each replicate.Reproductive Biology and Endocrinology 2006, 4:61 http://www.rbej.com/content/4/1/61
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TRP53 dependent expression of Bax in cultured blastocysts Figure 5
TRP53 dependent expression of Bax in cultured blastocysts.(A) Western blotting analysis using anti-Bax antibody of 
blastocysts collected from the uterus on day 4 (Fresh) or of embryos produced by IVF and cultured for 96 h (113 h post hCG). 
The embryos were extracted as groups of 20, 40 or 80 embryos and then subjected to Western blotting analysis. Approxi-
mately 500 F9 cells were also analyzed as positive controls. The blots shown are representative of 3 experiments. (B) The 
localization of Bax by indirect immunofluorescence (using same antibody as in Western blot analysis) with blastocysts collected 
from the uterus (Fresh) or those fertilized within the reproductive tract and the cultured for 96 h (Cultured) (113 h post 
hCG). Controls were subjected to IgG instead of primary antibody (IgG). The cultures were performed with Trp53+/+ and 
Trp53-/- embryos. Whole section images were deconvoluted and converted to pseudocolor representation of staining intensity. 
The sections shown are representative of 3 replicate experiments with a minimum of 8 embryos per treatment per replicate.Reproductive Biology and Endocrinology 2006, 4:61 http://www.rbej.com/content/4/1/61
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glucose concentrations [24], may suggest that it plays
some role. TRP53 induces the expression of many genes
and an important research question for the future will be
to characterise the TRP53-induced transcriptome in the
cultured early embryo in preimplantation stage viability.
Embryos that have Mdm2 activity deleted (Mdm2-/-) [15-
17] show early lethality, and this was abrogated in the
Mdm2-/-Trp53-/- compound mutant. MDM2 acts as an E3
ubiquitin ligase that leads to ubiquitination and rapid
degradation by the 26S proteasome of its targets, the most
important of which is TRP53 [25,26]. The action of
MDM2 is largely responsible for the short half-life of
TRP53 in cells not subjected to stresses [23]. It is this deg-
radation that accounts for the latency of TRP53 expression
in most unstressed cells. MDM2 expression is in turn reg-
ulated by TRP53; the MDM2 promoter contains TRP53
consensus binding sites. Thus, MDM2 and TRP53 are rec-
ognised to form an autoregulatory feedback loop [27].
This study showed that the use of embryo's from mouse
strains (such as the B6) that are susceptible to the various
stresses of culture provide a useful model for the investi-
gation of the cellular mechanisms of embryos response to
culture. The use of this strain has the additional advantage
that many gene knockout models are produced in the B6
The effect of Trp53-/-genotype and the density of zygote culture on the development of zygotes in vitro Figure 6
The effect of Trp53-/- genotype and the density of zygote culture on the development of zygotes in vitro. The 
results represent the proportion of zygotes that developed to morphologically normal blastocysts 113 h post hCG. The 
number of embryos in each treatment is shown in brackets. * shows a significant difference p < 0.01 compared with Trp53-/- 
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background. The combined use of genetically modified
animal models, experimental ART and modern cell biol-
ogy provide the opportunity to ask fundamental ques-
tions about the embryos response to its culture
environment.
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